
KLOW Blend 80mg
$199.00
Four-peptide vial: GHK-Cu, BPC-157, TB-500 and KPV, 80 mg total.
For laboratory research use only. Not for human or veterinary use. By ordering you confirm you are 18 or older and are purchasing for lawful research.
Availability: 25 in stock
- Content per vial
- 80 mg (4 components)
- Vial
- 3 mL vial
- Form
- Lyophilised powder
- Unopened, long term
- −20 °C, protected from light
Bacteriostatic water for the lab
Research peptides are supplied as a lyophilised powder. Bacteriostatic water is the standard laboratory solvent for reconstituting them, and ours is independently tested. For laboratory research use only.
Description
KLOW is a four-component research blend combining GHK-Cu, BPC-157, TB-500 and the tripeptide KPV (Lys-Pro-Val) in a single vial.
Nominal composition is 50 mg GHK-Cu with 10 mg each of BPC-157, TB-500 and KPV (80 mg total), supplied as lyophilised powder in a 3 mL vial.
Measured by Janoshik Analytical (report #218226): GHK-Cu 52.35 mg, BPC-157 11.51 mg, TB-500 11.55 mg and KPV 11.54 mg, each measured separately. This test covered identity and amount; purity was not part of it.
New to KLOW? Read what KLOW peptide is: the four components and how a blend is tested.
Research background
KLOW combines four peptides that are each studied separately. GHK-Cu is the copper(II) complex of the plasma tripeptide glycyl-L-histidyl-L-lysine, studied in research on copper-binding peptides and extracellular-matrix proteins. BPC-157 is a synthetic 15-amino-acid peptide derived from a gastric-juice protein, studied mainly in rodent models. TB-500 is based on the actin-binding region of thymosin beta-4, a protein studied in research on the actin cytoskeleton and cell migration. KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (α-MSH), studied in cell and animal models of inflammatory signalling, including its uptake through the PepT1 peptide transporter.
There is no published research on this four-component blend as such; the literature below concerns the individual components.
Research stage: Preclinical. None of the components is approved for therapeutic use in this form.
Selected published research
- Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987. PubMed 29986520
- Gwyer D, Wragg NM, Wilson SL. Cell Tissue Res. 2019;377(2):153-159. PubMed 30915550
- Goldstein AL, Hannappel E, Sosne G, et al. Expert Opin Biol Ther. 2012;12(1):37-51. PubMed 22074294
- Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. Gastroenterology. 2008;134(1):166-178. PubMed 18061177
This section summarises the subject of published research for reference only. It does not describe the effects of this product, which is supplied for laboratory research use only and is not for human or veterinary use.
Background reading: KLOW blend: the four peptides in one vial
Specifications
| Product | KLOW Blend 80mg |
|---|---|
| SKU | APX-KLOW-80 |
| Category | Peptide blends |
| Content per vial | 80 mg (4 components) |
| Vial | 3 mL vial |
| Form | Lyophilised powder |
| Components (nominal) | GHK-Cu 50 mg; BPC-157 10 mg; TB-500 10 mg; KPV 10 mg |
| KPV sequence | Lys-Pro-Val |
| Intended use | Laboratory research only |
Storage
| Unopened, long term | −20 °C, protected from light |
|---|---|
| Unopened, short term | 2–8 °C for up to several weeks |
| After reconstitution | 2–8 °C; record the preparation date on the vial |
| Handling | Allow the vial to reach room temperature before opening to limit moisture uptake |
General guidance only. Follow your institution’s procedures for handling research materials.
Testing & COA
Third-party analysis by Janoshik Analytical. Details below are transcribed from the report; the PDF is the authoritative copy.
| Laboratory | Janoshik Analytical |
|---|---|
| Task number | #218226 |
| Sample as recorded | Klow 80mg |
| Tests requested | KLOW (GHK or GHK-Cu/ TB-500/ BPC-157/ KPV) analysis – ID and amount; peptide purity not included |
| Result: GHK-Cu | 52.35 mg |
| Result: GHK content | 46.48 mg |
| Result: Copper content | 5.87 mg |
| Result: BPC-157 | 11.51 mg |
| Result: TB-500 (TB4) | 11.55 mg |
| Result: KPV | 11.54 mg |
| Purity | Not reported for this test |
| Batch on report | White lids |
| Sample received | 07 Aug 2026 |
| Analysis conducted | 11 Aug 2026 |
| Verification key | V8BDMI927L2F |
Janoshik report #218226PDFCommon questions
How much is actually in the vial?
Janoshik Analytical measured 52.35 mg GHK-Cu, 11.51 mg BPC-157, 11.55 mg TB-500 (TB4) and 11.54 mg KPV in the vial it tested (report #218226, 11 Aug 2026). The label states 80 mg (4 components). Measured amounts vary a little from batch to batch; the full results list everything the report covers.
How do I check the lab report is genuine?
Go to janoshik.com/verify and enter the key V8BDMI927L2F. It brings up Janoshik's own record of test #218226, so you can confirm the PDF on this page matches what the laboratory issued.
What is it reconstituted with in the lab?
KLOW Blend 80mg is supplied as a dry, lyophilised powder. In the laboratory, lyophilised peptides are usually reconstituted with bacteriostatic water, the standard laboratory solvent, which we stock in 3mL and 10mL vials (for laboratory research use only). See the storage notes above for unopened and reconstituted vials.
How long does shipping take in Australia?
Orders are dispatched within 1 business day of payment and sent by Australia Post Express Post with tracking, which usually arrives the next business day across most of the Express Post network (allow a few extra days for regional areas). Express Post is a $15 flat rate, or free on orders of $250 or more. We ship within Australia only. See the shipping policy.
How do I pay?
By PayID or bank transfer. The payment details appear as soon as you place your order and are emailed to you as well. Your order is dispatched once the payment arrives.
Disclaimer
KLOW Blend 80mg is supplied for in-vitro and laboratory research only. It is not intended to diagnose, treat, cure or prevent any disease, and is not registered or listed on the Australian Register of Therapeutic Goods. Descriptions on this page summarise published chemical information and do not describe effects in humans or animals.
The purchaser is responsible for safe handling, storage and disposal, and for complying with all laws that apply to them. See the full Disclaimer and Research use terms.





Reviews
There are no reviews yet.